Patents by Inventor Anders Wallenborg

Anders Wallenborg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11883571
    Abstract: An extracorporeal blood treatment apparatus includes a filtration unit (2) connected to a blood circuit (17) and a dialysate circuit (32), a preparation device (9) for preparing and regulating the composition of the dialysis fluid, and a sensor (11) for measuring conductivity of the dialysate (i.e. spent dialysis fluid); a control unit (12) configured for setting a sodium concentration in the dialysis fluid and after setting the dialysis fluid at the initial set point, circulating the dialysis fluid and blood through the filtration unit (2), measuring an initial conductivity value of the dialysate at the beginning of the treatment, and calculating, based on the measured initial conductivity value and on the corresponding conductivity value of the dialysis fluid, the value of the initial plasma conductivity, said circulating of the dialysis fluid up to the calculating of the initial plasma conductivity performed by maintaining the dialysis fluid conductivity substantially constant.
    Type: Grant
    Filed: April 15, 2020
    Date of Patent: January 30, 2024
    Assignee: Gambro Lundia AB
    Inventors: Paolo Rovatti, Alessandro Surace, Carlo Alberto Lodi, Anders Wallenborg, Anders Nilsson, Kristian Solem, Jan Sternby, Thomas Hertz
  • Patent number: 11690946
    Abstract: A blood treatment apparatus is disclosed. The example apparatus includes a blood treatment unit including a fluid inlet and a fluid outlet and a blood line. The apparatus also includes a fluid line including an upstream fluid line configured to receive electrically conductive treatment fluid from a fluid source and pass the electrically conductive treatment fluid to the fluid inlet of the blood treatment unit and a downstream fluid line connected to the fluid outlet of the blood treatment unit for delivering the used electrically conductive treatment fluid to a fluid sink. The apparatus further includes a flow divider arranged in the downstream fluid line and configured to separate the used electrically conductive treatment fluid in the downstream fluid line into to a first fluid section and a second fluid section, thereby electrically isolating the first and second fluid sections.
    Type: Grant
    Filed: April 28, 2021
    Date of Patent: July 4, 2023
    Assignee: Gambro Lundia AB
    Inventors: Per Hansson, Thomas Hertz, Mattias Holmer, Lennart Jonsson, Anders Nilsson, Anders Wallenborg, Johan Andersson
  • Publication number: 20220347363
    Abstract: Methods, apparatuses, and systems for determining a correlation between intraperitoneal pressure (“IPP”) measurements and patient intraperitoneal volume (“IPV”) are disclosed. In an example, an apparatus is configured to determine a maximum fill volume of dialysate to be pumped into a peritoneal cavity of a patient. The apparatus also determines a plurality of iterations to achieve the maximum fill volume and a volume of the dialysate to be pumped for each of the iterations. For each iteration, the apparatus causes a dialysis machine to pump the dialysate to the peritoneal cavity based on the determined volume for that iteration, records IPP measurement output data from a pressure sensor, records or determines a total accumulated fill volume, and creates a data point for a personalized patient model corresponding to a correlation between the IPP measurement output data and the total accumulated fill volume.
    Type: Application
    Filed: May 2, 2022
    Publication date: November 3, 2022
    Inventors: Christian Antero Vartia, Carlos Alberto Corrales Nogales, Joanna Rita Yanaga, Jorge Del Castillo, Per-Olof Borgqvist, Anders Wallenborg, John Sterling Norman, Jeannette Aguilar, Madison Rachel Hedlund, Caesar Gudani
  • Patent number: 11426501
    Abstract: An extracorporeal blood treatment apparatus is provided comprising a filtration unit (2) connected to a blood circuit (17) and to a dialysate circuit (32), a preparation device (9) for preparing and regulating the composition of the dialysis fluid, and a sensor (11) for measuring conductivity of the dialysate (i.e.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: August 30, 2022
    Assignee: Gambro Lundia AB
    Inventors: Anders Wallenborg, Anders Nilsson, Kristian Solem, Thomas Hertz, Paolo Rovatti, Carlo Alberto Lodi, Alessandro Surace, Jan Sternby
  • Patent number: 11383012
    Abstract: An extracorporeal blood treatment apparatus is provided comprising a filtration unit (2) connected to a blood circuit (17) and to a dialysate circuit (32), a preparation device (9) for preparing and regulating the composition of the dialysis fluid; a control unit (12) is configured for setting a sodium concentration value for the dialysis fluid in the dialysis supply line (8) at a set point; the setting of the sodium concentration includes the sub-step of calculating the sodium concentration value as an algebraic sum of a main contribution term based on the blood plasma conductivity and of an adjustment contribution term based on a concentration of at least a substance in the dialysis fluid chosen in the group including bicarbonate, potassium, acetate, lactate, citrate, magnesium, calcium, sulphate, and phosphate.
    Type: Grant
    Filed: October 26, 2017
    Date of Patent: July 12, 2022
    Assignee: Gambro Lundia AB
    Inventors: Anders Wallenborg, Anders Nilsson, Kristian Solem, Thomas Hertz, Paolo Rovatti, Carlo Alberto Lodi, Alessandro Surace, Jan Sternby
  • Publication number: 20210244872
    Abstract: A blood treatment apparatus is disclosed. The example apparatus includes a blood treatment unit including a fluid inlet and a fluid outlet and a blood line. The apparatus also includes a fluid line including an upstream fluid line configured to receive electrically conductive treatment fluid from a fluid source and pass the electrically conductive treatment fluid to the fluid inlet of the blood treatment unit and a downstream fluid line connected to the fluid outlet of the blood treatment unit for delivering the used electrically conductive treatment fluid to a fluid sink. The apparatus further includes a flow divider arranged in the downstream fluid line and configured to separate the used electrically conductive treatment fluid in the downstream fluid line into to a first fluid section and a second fluid section, thereby electrically isolating the first and second fluid sections.
    Type: Application
    Filed: April 28, 2021
    Publication date: August 12, 2021
    Inventors: Per HANSSON, Thomas HERTZ, Mattias HOLMER, Lennart JONSSON, Anders NILSSON, Anders WALLENBORG, Johan ANDERSSON
  • Patent number: 11000641
    Abstract: A blood treatment apparatus is disclosed. In an example, the blood treatment apparatus includes a blood treatment unit; a blood line configured to extract blood from a blood source, pass the blood through the blood treatment unit and deliver treated blood to a target vessel; and a fluid line configured to pass treatment fluid through the blood treatment unit and deliver used treatment fluid to a fluid sink. A flow divider is arranged in the fluid line for separating treatment fluid into to a first fluid section and a second fluid section, thereby electrically isolating the fluid sections such that electrical current flowing in the fluid line between the fluid sections is limited. Related manufacturing and verification methods are also described.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: May 11, 2021
    Assignee: Gambro Lundia AB
    Inventors: Per Hansson, Thomas Hertz, Mattias Holmer, Lennart Jonsson, Anders Nilsson, Anders Wallenborg, Johan Andersson
  • Patent number: 10729835
    Abstract: A monitoring device operates on a pressure signal from a blood processing apparatus which has an extracorporeal blood circuit for pumping blood through a dialyzer, and a treatment fluid supply system for pumping a treatment fluid through the dialyzer. The monitoring device has a first input block for obtaining a first pressure signal, and a second input block for obtaining a second pressure signal. An emulation block generates, as a function of the second pressure signal, an emulated first pressure signal which emulates a concurrent signal response of the first pressure sensor, and a filtering block generates a filtered signal as a function of the first pressure signal and the emulated first pressure signal, so as to suppress, in the filtered signal compared to the first pressure signal, signal interferences originating from the treatment fluid supply system. A pulse detection block processes the filtered signal for detection of subject pulses.
    Type: Grant
    Filed: October 15, 2018
    Date of Patent: August 4, 2020
    Assignee: GAMBRO LUNDIA AB
    Inventors: Jan Sternby, Mattias Holmer, Bo Olde, Kristian Solem, Anders Wallenborg, Per Hansson
  • Publication number: 20200237990
    Abstract: An extracorporeal blood treatment apparatus includes a filtration unit (2) connected to a blood circuit (17) and a dialysate circuit (32), a preparation device (9) for preparing and regulating the composition of the dialysis fluid, and a sensor (11) for measuring conductivity of the dialysate (i.e. spent dialysis fluid); a control unit (12) configured for setting a sodium concentration in the dialysis fluid and after setting the dialysis fluid at the initial set point, circulating the dialysis fluid and blood through the filtration unit (2), measuring an initial conductivity value of the dialysate at the beginning of the treatment, and calculating, based on the measured initial conductivity value and on the corresponding conductivity value of the dialysis fluid, the value of the initial plasma conductivity, said circulating of the dialysis fluid up to the calculating of the initial plasma conductivity performed by maintaining the dialysis fluid conductivity substantially constant.
    Type: Application
    Filed: April 15, 2020
    Publication date: July 30, 2020
    Inventors: Paolo ROVATTI, Alessandro SURACE, Carlo Alberto LODI, Anders WALLENBORG, Anders NILSSON, Kristian SOLEM, Jan STERNBY, Thomas HERTZ
  • Publication number: 20200155745
    Abstract: A system (1) and a method for renal replacement therapy comprising a blood treatment unit (4) connected to a blood circuit (2) and a dialysis fluid circuit (3), the system (1) further comprises a control unit (31) configured to control the system (1) according to control instructions comprising to, during a treatment, determine a system parameter value and an indication of membrane fouling of the membrane (7), and activate an automatic anti-fouling measure comprising a temporary change of the flow rate in the blood circuit (2) and a temporary decrease of the ultrafiltration rate wherein a timing of the temporary change and a timing of the temporary reduction are synchronized.
    Type: Application
    Filed: June 21, 2018
    Publication date: May 21, 2020
    Inventors: Roger NILSSON, Björn ERICSON, Jan STERNBY, Thomas HERTZ, Olof JANSSON, Sture HOBRO, Anders WALLENBORG, Jonas FORS, Henrik LINDGREN, Annmargret HÅKANSSON
  • Patent number: 10646632
    Abstract: An extracorporeal blood treatment apparatus is provided comprising a filtration unit (2) connected to a blood circuit (17) and to a dialysate circuit (32), a preparation device (9) for preparing and regulating the composition of the dialysis fluid, and a sensor (11) for measuring conductivity of the dialysate (i.e.
    Type: Grant
    Filed: May 23, 2016
    Date of Patent: May 12, 2020
    Assignee: GAMBRO LUNDIA AB
    Inventors: Paolo Rovatti, Alessandro Surace, Carlo Alberto Lodi, Anders Wallenborg, Anders Nilsson, Kristian Solem, Jan Sternby, Thomas Hertz
  • Publication number: 20190374697
    Abstract: An extracorporeal blood treatment apparatus is provided comprising a filtration unit (2) connected to a blood circuit (17) and to a dialysate circuit (32), a preparation device (9) for preparing and regulating the composition of the dialysis fluid, and a sensor (11) for measuring conductivity of the dialysate (i.e.
    Type: Application
    Filed: October 27, 2017
    Publication date: December 12, 2019
    Inventors: Anders Wallenborg, Anders Nilsson, Kristian Solem, Thomas Hertz, Paolo Rovatti, Carlo Alberto Lodi, Alessandro Surace, Jan Sternby
  • Patent number: 10493197
    Abstract: A blood treatment apparatus comprising: a blood treatment unit; a blood line configured to extract blood from a blood source, pass the blood through the blood treatment unit and deliver treated blood to a target vessel; and a fluid line configured to pass treatment fluid through the blood treatment unit and deliver used treatment fluid to a fluid sink. A flow divider is arranged in the fluid line that separates treatment fluid into a first fluid section and a second fluid section, thereby electrically isolating the fluid sections such that electrical current flowing in the fluid line between the fluid sections is limited. Related manufacturing and verification methods are also described.
    Type: Grant
    Filed: September 14, 2011
    Date of Patent: December 3, 2019
    Assignee: GAMBRO LUNDIA AB
    Inventors: Per Hansson, Thomas Hertz, Mattias Holmer, Lennart Jonsson, Anders Nilsson, Anders Wallenborg, Johan Andersson
  • Patent number: 10434236
    Abstract: An extracorporeal blood treatment apparatus is provided comprising a filtration unit (2) connected to a blood circuit (17) and to a dialysate circuit (32), a preparation device (9) for preparing and regulating the composition of the dialysis fluid; a control unit (12) is configured for setting a sodium concentration value for the dialysis fluid in the dialysis supply line (8) at a set point; the setting of the sodium concentration includes the sub-step of calculating the sodium concentration value as an algebraic sum of a main contribution term based on the blood plasma conductivity and of an adjustment contribution term based on a concentration of at least a substance in the dialysis fluid chosen in the group including bicarbonate, potassium, acetate, lactate, citrate, magnesium, calcium, sulphate, and phosphate.
    Type: Grant
    Filed: May 23, 2016
    Date of Patent: October 8, 2019
    Assignee: Gambro Lundia AB
    Inventors: Paolo Rovatti, Alessandro Surace, Carlo Alberto Lodi, Anders Wallenborg, Anders Nilsson, Kristian Solem, Jan Sternby, Thomas Hertz
  • Publication number: 20190275230
    Abstract: An extracorporeal blood treatment apparatus is provided comprising a filtration unit (2) connected to a blood circuit (17) and to a dialysate circuit (32), a preparation device (9) for preparing and regulating the composition of the dialysis fluid; a control unit (12) is configured for setting a sodium concentration value for the dialysis fluid in the dialysis supply line (8) at a set point; the setting of the sodium concentration includes the sub-step of calculating the sodium concentration value as an algebraic sum of a main contribution term based on the blood plasma conductivity and of an adjustment contribution term based on a concentration of at least a substance in the dialysis fluid chosen in the group including bicarbonate, potassium, acetate, lactate, citrate, magnesium, calcium, sulphate, and phosphate.
    Type: Application
    Filed: October 26, 2017
    Publication date: September 12, 2019
    Inventors: Anders Wallenborg, Anders Nilsson, Kristian Solem, Thomas Hertz, Paolo Rovatti, Carlo Alberto Lodi, Alessandro Surace, Jan Sternby
  • Publication number: 20190046709
    Abstract: A monitoring device operates on a pressure signal from a blood processing apparatus which has an extracorporeal blood circuit for pumping blood through a dialyzer, and a treatment fluid supply system for pumping a treatment fluid through the dialyzer. The monitoring device has a first input block for obtaining a first pressure signal, and a second input block for obtaining a second pressure signal. An emulation block generates, as a function of the second pressure signal, an emulated first pressure signal which emulates a concurrent signal response of the first pressure sensor, and a filtering block generates a filtered signal as a function of the first pressure signal and the emulated first pressure signal, so as to suppress, in the filtered signal compared to the first pressure signal, signal interferences originating from the treatment fluid supply system. A pulse detection block processes the filtered signal for detection of subject pulses.
    Type: Application
    Filed: October 15, 2018
    Publication date: February 14, 2019
    Inventors: Jan Sternby, Mattias Holmer, Bo Olde, Kristian Solem, Anders Wallenborg, Per Hansson
  • Patent number: 10137233
    Abstract: A monitoring device (7) operates on a pressure signal from a blood processing apparatus, e.g. a dialysis machine, which has an extracorporeal blood circuit connected to a vascular system of a subject for pumping blood through a dialyzer, and a treatment fluid supply system for pumping a treatment fluid through the dialyzer. The monitoring device (7) has a first input block (50) for obtaining a first pressure signal (y) from a first pressure sensor (6a) in the extracorporeal blood circuit, and a second input block (51) for obtaining a second pressure signal (w) from a second pressure sensor (6b) in the treatment fluid supply system.
    Type: Grant
    Filed: December 11, 2013
    Date of Patent: November 27, 2018
    Assignee: GAMBRO LUNDIA AB
    Inventors: Jan Sternby, Mattias Holmer, Bo Olde, Kristian Solem, Anders Wallenborg, Per Hansson
  • Publication number: 20180169315
    Abstract: An extracorporeal blood treatment apparatus is provided comprising a filtration unit (2) connected to a blood circuit (17) and to a dialysate circuit (32), a preparation device (9) for preparing and regulating the composition of the dialysis fluid, and a sensor (11) for measuring conductivity of the dialysate (i.e.
    Type: Application
    Filed: May 23, 2016
    Publication date: June 21, 2018
    Inventors: Paolo ROVATTI, Alessandro SURACE, Cario Alberto LODI, Anders WALLENBORG, Anders NILLSON, Kristian SOLEM, Jan STERNBY, Thomas HERTZ
  • Publication number: 20180140761
    Abstract: An extracorporeal blood treatment apparatus is provided comprising a filtration unit (2) connected to a blood circuit (17) and to a dialysate circuit (32), a preparation device (9) for preparing and regulating the composition of the dialysis fluid; a control unit (12) is configured for setting a sodium concentration value for the dialysis fluid in the dialysis supply line (8) at a set point; the setting of the sodium concentration includes the sub-step of calculating the sodium concentration value as an algebraic sum of a main contribution term based on the blood plasma conductivity and of an adjustment contribution term based on a concentration of at least a substance in the dialysis fluid chosen in the group including bicarbonate, potassium, acetate, lactate, citrate, magnesium, calcium, sulphate, and phosphate.
    Type: Application
    Filed: May 23, 2016
    Publication date: May 24, 2018
    Inventors: Paolo Rovatti, Alessandro Surace, Cario Alberto Lodi, Anders Wallenborg, Anders Nilsson, Kristian Solem, Jan Sternby, Thomas Hertz
  • Publication number: 20150306293
    Abstract: A monitoring device (7) operates on a pressure signal from a blood processing apparatus, e.g. a dialysis machine, which has an extracorporeal blood circuit connected to a vascular system of a subject for pumping blood through a dialyzer, and a treatment fluid supply system for pumping a treatment fluid through the dialyzer. The monitoring device (7) has a first input block (50) for obtaining a first pressure signal (y) from a first pressure sensor (6a) in the extracorporeal blood circuit, and a second input block (51) for obtaining a second pressure signal (w) from a second pressure sensor (6b) in the treatment fluid supply system.
    Type: Application
    Filed: December 11, 2013
    Publication date: October 29, 2015
    Inventors: Jan Sternby, Mattias Holmer, Bo Olde, Kristian Solem, Anders Wallenborg, Per Hansson